Pharma Open Data Space: Turning Vision into Reality - Roadmap for Resilience, Data Integrity and Business Impact

Data exchange is no longer just a technical goal; it is a survival strategy for a resilient supply chain as well as eliminating manual and error prone process steps to ensure patient safety. In this interactive forum, we move beyond the "if" and into the "how" in a regulated pharmaceutical environment. We compare Pharma's progress to breakthrough successes in industries like steel manufacturing and Construction sectors (from building facades to digital twins) to see how open data drives radical resilience. This session explores the Pharma Open Data Space (PODS) as the essential enabler for the next generation of R&D and manufacturing. We bridge the gap between vision and reality by examining what is happening outside Pharma - learning from the interoperability of the other industries - and showcasing how leaders are already implementing these frameworks. Learn how to maintain 100% data ownership while enabling seamless, secure collaboration with CDMOs and suppliers, without drowning in Excel, Word and PDF files. We will dive deep into the Business Incentive: reducing operational friction, ensuring Data Integrity through the Asset Administration Shell (AAS), and enabling Automation through technologies such as Module Type Package (MTP). This interactive forum provides the real takeaways and next steps needed to move your organization from isolated data silos to a high-impact, federated ecosystem. This is not just a Unified namespace.

Key Takeaways:
•Cross-Industry Intelligence: Lessons from industries like Steel, and Construction on federated data sovereignty.
•The ROI of Openness: How a holistic "Plug & Produce" integration slashes tech-transfer times and costs.
•Integrity & Resilience: Scaling ALCOA+ standards across decentralized supply chain partners along the pharmaceutical product lifecycle.
•Next Steps: Practical Proof of Concept /PoC frameworks and reference models to start your PODS journey.

Adrian Widmer

Roche Digital, AI & Operational Excellence, Roche

Appearances